{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T17:08:31Z","timestamp":1783962511737,"version":"3.55.0"},"reference-count":42,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,7,2]],"date-time":"2018-07-02T00:00:00Z","timestamp":1530489600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007343","name":"Shire","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007343","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2018.01308","type":"journal-article","created":{"date-parts":[[2018,7,2]],"date-time":"2018-07-02T00:16:23Z","timestamp":1530490583000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":30,"title":["What Is the Burden of Immunoglobulin Replacement Therapy in Adult Patients With Primary Immunodeficiencies? A Systematic Review"],"prefix":"10.3389","volume":"9","author":[{"given":"Georgina L.","family":"Jones","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina S.","family":"Vogt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duncan","family":"Chambers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Clowes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Shrimpton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,7,2]]},"reference":[{"key":"B1","unstructured":"Types of Primary Immunodeficieny Disorders2013"},{"key":"B2","doi-asserted-by":"publisher","first-page":"621","DOI":"10.2147\/PPA.S60771","article-title":"Improving current immunoglobulin therapy for patients with primary immunodeficiency: quality of life and views on treatment","volume":"8","author":"Espanol","year":"2014","journal-title":"Patient Prefer Adherence"},{"key":"B3","first-page":"23","article-title":"Health-related quality of life in primary immune deficient patients","volume":"5","author":"Mozaffari","year":"2006","journal-title":"Iran J Allergy Asthma Immunol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"157","DOI":"10.2147\/TCRM.S22599","article-title":"Human normal immunoglobulin in the treatment of primary immunodeficiency diseases","volume":"8","author":"Wood","year":"2012","journal-title":"Ther Clin Risk Manag"},{"key":"B5","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1111\/hex.12046","article-title":"Burden of treatment for chronic illness: a concept analysis and review of the literature","volume":"18","author":"Sav","year":"2015","journal-title":"Health Expect"},{"key":"B6","doi-asserted-by":"publisher","first-page":"7","DOI":"10.2147\/PROM.S44694","article-title":"A systematic review of patient-reported measures of burden of treatment in three chronic diseases","volume":"4","author":"Eton","year":"2013","journal-title":"Patient Relat Outcome Meas"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2147\/TCRM.S4353","article-title":"Subcutaneous immunoglobulin replacement therapy in the treatment of patients with primary immunodeficiency disease","volume":"6","author":"Skoda-Smith","year":"2010","journal-title":"Ther Clin Risk Manag"},{"key":"B8","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1111\/j.1365-2249.2009.04027.x","article-title":"Subcutaneous immunoglobulin: opportunities and outlook","volume":"158","author":"Misbah","year":"2009","journal-title":"Clin Exp Immunol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"603","DOI":"10.3349\/ymj.2012.53.3.603","article-title":"Health related quality of life in common variable immunodeficiency","volume":"53","author":"Quinti","year":"2012","journal-title":"Yonsei Med J"},{"key":"B10","doi-asserted-by":"publisher","first-page":"605","DOI":"10.3389\/fimmu.2014.00605","article-title":"Longitudinal study on health-related quality of life in a cohort of 96 patients with common variable immune deficiencies","volume":"5","author":"Tabolli","year":"2014","journal-title":"Front Immunol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s13223-015-0092-y","article-title":"Health-related quality of life in patients with primary immunodeficiency disease","volume":"11","author":"Jiang","year":"2015","journal-title":"Allergy Asthma Clin Immunol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1007\/s10875-015-0201-1","article-title":"Primary immunodeficiency diseases: an update on the classification from the International Union of Immunological Societies Expert Committee for primary immunodeficiency 2015","volume":"35","author":"Picard","year":"2015","journal-title":"J Clin Immunol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1111\/j.1759-8893.2011.00076.x","article-title":"Patients with primary immunodeficiency receiving subcutaneous immune globulin Hizentra maintain health-related quality of life and treatment satisfaction in a multicentre extension study of efficacy, tolerability and safety","volume":"3","author":"Jones","year":"2012","journal-title":"J Pharm Heal Serv Res"},{"key":"B14","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1017\/S0266462300006942","article-title":"A comparison of the patient-borne costs of therapy with gamma globulin given at the hospital or at home","volume":"11","author":"Gardulf","year":"1995","journal-title":"Int J Technol Assess Health Care"},{"key":"B15","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.clim.2005.11.002","article-title":"The health status and quality of life of adults with X-linked agammaglobulinemia","volume":"118","author":"Howard","year":"2005","journal-title":"Clin Immunol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1007\/s10875-016-0279-0","article-title":"Health-related quality of life and health resource utilization in patients with primary immunodeficiency disease prior to and following 12 months of immunoglobulin G treatment","volume":"36","author":"Routes","year":"2016","journal-title":"J Clin Immunol"},{"key":"B17","first-page":"504","article-title":"Home-based immunoglobulin infusion therapy: quality of life and patient health perceptions","volume":"67","author":"Daly","year":"1991","journal-title":"Ann Allergy"},{"key":"B18","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s10875-006-8905-x","article-title":"Health-related quality of life and treatment satisfaction in North American patients with primary immunedeficiency diseases receiving subcutaneous IgG self-infusions at home","volume":"26","author":"Nicolay","year":"2006","journal-title":"J Clin Immunol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.3111\/13696998.2012.716804","article-title":"Patient and parent preferences for immunoglobulin treatments: a conjoint analysis","volume":"15","author":"Mohamed","year":"2012","journal-title":"J Med Econ"},{"key":"B20","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1111\/j.1365-2249.1993.tb03380.x","article-title":"The life situations of patients with primary antibody deficiency untreated or treated with subcutaneous gammaglobulin infusions","volume":"92","author":"Gardulf","year":"1993","journal-title":"Clin Exp Immunol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1007\/s10875-011-9588-5","article-title":"Efficacy and safety of subcutaneous vivaglobin replacement therapy in previously untreated patients with primary immunodeficiency: a prospective, multicenter study","volume":"31","author":"Borte","year":"2011","journal-title":"J Clin Immunol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/S1081-1206(10)61469-X","article-title":"Quality of life in common variable immunodeficiency requiring intravenous immunoglobulin therapy","volume":"93","author":"Tcheurekdjian","year":"2004","journal-title":"Ann Allergy Asthma Immunol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1023\/A:1006678312925","article-title":"The comparison of the efficacy and safety of intravenous versus subcutaneous immunoglobulin replacement therapy","volume":"20","author":"Chapel","year":"2000","journal-title":"J Clin Immunol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"e0131565","DOI":"10.1371\/journal.pone.0131565","article-title":"Experience with subgam, a subcutaneously administered human normal immunoglobulin (ClinicalTrials.gov \u2013 NCT02247141)","volume":"10","author":"Dash","year":"2015","journal-title":"PLoS One"},{"key":"B25","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1046\/j.1365-2648.1995.21050917.x","article-title":"Lifelong treatment with gammaglobulin for primary antibody deficiencies: the patients\u2019 experiences of subcutaneous self-infusions and home therapy","volume":"21","author":"Gardulf","year":"1995","journal-title":"J Adv Nurs"},{"key":"B26","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/0140-6736(91)90147-H","article-title":"Home treatment of hypogammaglobulinaemia with subcutaneous gammaglobulin by rapid infusion","volume":"338","author":"Gardulf","year":"1991","journal-title":"Lancet"},{"key":"B27","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1006\/clim.2002.5215","article-title":"Express subcutaneous IgG infusions: decreased time of delivery with maintained safety","volume":"104","author":"Hansen","year":"2002","journal-title":"Clin Immunol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1007\/s10875-006-9031-5","article-title":"Patients\u2019 attitude to subcutaneous immunoglobulin substitution as home therapy","volume":"26","author":"Kittner","year":"2006","journal-title":"J Clin Immunol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1007\/s10875-017-0404-8","article-title":"Health-related quality of life in adult patients with common variable immunodeficiency disorders and impact of treatment","volume":"37","author":"Rider","year":"2017","journal-title":"J Clin Immunol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1023\/A:1011051704960","article-title":"Rapid subcutaneous IgG replacement therapy at home for pregnant immunodeficient women","volume":"21","author":"Gardulf","year":"2001","journal-title":"J Clin Immunol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"627","DOI":"10.3389\/fimmu.2014.00627","article-title":"Primary immune deficiencies \u2013 principles of care","volume":"5","author":"Chapel","year":"2014","journal-title":"Front Immunol"},{"key":"B32","volume-title":"Launch of the \u201cBurden of Treatment\u201d Study in World PI Week","author":"PID","year":"2016"},{"key":"B33","doi-asserted-by":"publisher","first-page":"AB221","DOI":"10.1016\/j.jaci.2016.11.029","article-title":"Construction and validation of a novel disease-specific quality of life instrument for patients with primary antibody deficiency disease (PADQOL-16)","volume":"137","author":"Ballow","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1169.e","DOI":"10.1016\/j.jaip.2016.07.012","article-title":"Development and initial validation of a questionnaire to measure health-related quality of life of adults with common variable immune deficiency: the CVID_QoL questionnaire","volume":"4","author":"Quinti","year":"2016","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B35","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1016\/j.jaci.2004.06.053","article-title":"Children and adults with primary antibody deficiencies gain quality of life by subcutaneous IgG self-infusions at home","volume":"114","author":"Gardulf","year":"2004","journal-title":"J Allergy Clin Immunol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.clim.2007.06.009","article-title":"Prognostic factors for health-related quality of life in adults and children with primary antibody deficiencies receiving SCIG home therapy","volume":"126","author":"Gardulf","year":"2008","journal-title":"Clin Immunol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/s40261-015-0270-1","article-title":"Subcutaneous immunoglobulin replacement therapy in patients with primary immunodeficiency in routine clinical practice: the VISPO prospective multicenter study","volume":"35","author":"Vultaggio","year":"2015","journal-title":"Clin Drug Investig"},{"key":"B38","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1097\/SMJ.0b013e3181eba6ea","article-title":"Improved quality of life, immunoglobulin G levels, and infection rates in patients with primary immunodeficiency diseases during self-treatment with subcutaneous immunoglobulin G","volume":"103","author":"Berger","year":"2010","journal-title":"South Med J"},{"key":"B39","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s13023-016-0452-9","article-title":"Does the route of immunoglobin replacement therapy impact quality of life and satisfaction in patients with primary immunodeficiency? Insights from the French cohort \u201cVisages\u201d","volume":"11","author":"Bienvenu","year":"2016","journal-title":"Orphanet J Rare Dis"},{"key":"B40","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1016\/S0091-6749(87)80270-1","article-title":"Home treatment of antibody-deficiency syndromes with intravenous immune globulin","volume":"80","author":"Sorensen","year":"1987","journal-title":"J Allergy Clin Immunol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1111\/j.1365-2249.2009.04079.x","article-title":"Economic evaluation of immunoglobulin replacement in patients with primary antibody deficiencies (structured abstract)","volume":"160","author":"Beaute","year":"2009","journal-title":"Clin Exp Immunol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"409","DOI":"10.2500\/aap.2016.37.3977","article-title":"Anxiety and depression in adults with primary immunodeficiency: how much do these patients experience and how much do they attribute to their primary immunodeficiency?","volume":"37","author":"Heath","year":"2016","journal-title":"Allergy Asthma Proc"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2018.01308\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,7,2]],"date-time":"2018-07-02T00:17:00Z","timestamp":1530490620000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2018.01308\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,2]]},"references-count":42,"alternative-id":["10.3389\/fimmu.2018.01308"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2018.01308","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,2]]},"article-number":"1308"}}